Coverage for Continuous Glucose Monitoring for Individuals with Type 2 Diabetes Treated with Nonintensive Therapies: An Evidence-Based Approach to Policymaking

Numerous studies have demonstrated the clinical benefits of continuous glucose monitoring (CGM) in individuals with type 1 diabetes (T1D) and type 2 diabetes (T2D) who are treated with intensive insulin regimens. Based on this evidence, CGM is now a standard of care for individuals within these diab...

Descripción completa

Detalles Bibliográficos
Autores principales: Aleppo, Grazia, Hirsch, Irl B., Parkin, Christopher G., McGill, Janet, Galindo, Rodolfo, Kruger, Davida F., Levy, Carol J., Forlenza, Gregory P., Umpierrez, Guillermo E., Grunberger, George, Bergenstal, Richard M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611973/
https://www.ncbi.nlm.nih.gov/pubmed/37471068
http://dx.doi.org/10.1089/dia.2023.0268

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611973/
https://www.ncbi.nlm.nih.gov/pubmed/37471068
http://dx.doi.org/10.1089/dia.2023.0268

Ejemplares similares